Kestra Medical Technologies Ltd (NASDAQ: KMTS) open the trading on Wednesday, with a bit cautious approach as it glided -1.65% to $26.52, before settling in for the price of $26.97 at the close. Taking a more long-term approach, KMTS posted a 52-week range of $13.25-$30.00.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 55.05%. This publicly-traded company’s shares outstanding now amounts to $51.45 million, simultaneously with a float of $19.45 million. The organization now has a market capitalization sitting at $1.55 billion. At the time of writing, stock’s 50-day Moving Average stood at $26.25, while the 200-day Moving Average is $21.94.
Kestra Medical Technologies Ltd (KMTS) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Instruments & Supplies industry. Kestra Medical Technologies Ltd’s current insider ownership accounts for 66.67%, in contrast to 29.97% institutional ownership. According to the most recent insider trade that took place on Dec 29 ’25, this organization’s insider sold 10,500 shares at the rate of 26.69, making the entire transaction reach 280,201 in total value, affecting insider ownership by 136,633. Preceding that transaction, on Dec 29 ’25, Company’s insider sold 15,000 for 26.59, making the whole transaction’s value amount to 398,847. This particular insider is now the holder of 409,786 in total.
Kestra Medical Technologies Ltd (KMTS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year. Kestra Medical Technologies Ltd’s EPS increase for this current 12-month fiscal period is 55.05% and is forecasted to reach -2.11 in the upcoming year.
Kestra Medical Technologies Ltd (NASDAQ: KMTS) Trading Performance Indicators
Let’s observe the current performance indicators for Kestra Medical Technologies Ltd (KMTS). It’s Quick Ratio in the last reported quarter now stands at 5.27. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 20.84.
In the same vein, KMTS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.68, a figure that is expected to reach -0.60 in the next quarter, and analysts are predicting that it will be -2.11 at the market close of one year from today.
Technical Analysis of Kestra Medical Technologies Ltd (KMTS)
[Kestra Medical Technologies Ltd, KMTS] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 19.89% While, its Average True Range was 48.89.
Raw Stochastic average of Kestra Medical Technologies Ltd (KMTS) in the period of the previous 100 days is set at 77.69%, which indicates a major rise in contrast to 48.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.34 that was lower than 1.49 volatility it exhibited in the past 100-days period.
